Bovine osteopontin modifies the intestinal transcriptome of formula-fed infant rhesus monkeys to be more similar to those that were breastfed

Journal of Nutrition

Volumn 144, Issue 12, 2014, Pages 1910-1919

  Donovan, Sharon M ^a   Monaco, Marcia H ^a   Drnevich, Jenny ^a   Kvistgaard, Anne Staudt ^b   Hernell, Olle ^c   Lönnerdal, Bo ^d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Arla Foods   (Denmark)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breastfeeding; Infant; Intestine; Micorarray; Osteopontin

Indexed keywords

MESSENGER RNA; OSTEOPONTIN; TRANSCRIPTOME;

ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BREAST FEEDING; CELL ADHESION; CONTROLLED STUDY; DIET SUPPLEMENTATION; GENE EXPRESSION; IMMUNOCOMPETENT CELL; INFANT; MICROARRAY ANALYSIS; NEWBORN; NONHUMAN; RHESUS MONKEY; SAFETY; ANIMAL; ANIMAL FOOD; BOVINAE; CHEMISTRY; DIET; DRUG EFFECTS; INTESTINE; METABOLISM; MILK;

BOVINAE; MACACA MULATTA;

ANIMAL FEED; ANIMALS; ANIMALS, NEWBORN; BODY COMPOSITION; CATTLE; DIET; DIETARY SUPPLEMENTS; INTESTINES; MACACA MULATTA; MICROARRAY ANALYSIS; MILK; OSTEOPONTIN; TRANSCRIPTOME;

EID: 84912032574     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.197558     Document Type: Article

References (64)

1. Section on Breast feeding Breastfeeding and the use of human milk. Pediatrics 2012;129:e827-41.
2. Breastfeeding report card-United States [Internet]. 2012 [cited 2012 Oct 23]. Available from: http://www.cdc.gov/breastfeeding/pdf/ 2012BreastfeedingReportCard.pdf.
3. Lönnerdal B. Personalizing nutrient intakes of formula-fed infants: breast milk as a model. Nestle Nutr Workshop Ser Pediatr Program 2008;62:189-98.
4. Sandström O, Lönnerdal B, Graverholt G, Hernell O. Effects of alpha-lactalbumin-enriched formula containing different concentrations of glycomacropeptide on infant nutrition. Am J Clin Nutr 2008;87:921-8.
5. Gutiérrez-Castrell Ón P, Mora-Magaña I, Díaz-García L, Jiménez-Gutiérrez C, Ramirez-Mayans J, Solomon-Santib Áñez GA. Immune response to nucleotide-supplemented infant formulae: Systematic review and meta-analysis. Br J Nutr 2007;98: Suppl 1:S64-7.
6. Simmer K, Patole SK, Rao SC. Long-chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2011;12:CD000376 (DOI: 10.1002/14651858.CD000376.pub3).
7. Mugambi MN, Musekiwa A, Lombard M, Young T, Blaauw R. Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: A systematic review. BMC Med Res Methodol 2013;13:137.
8. Chouraqui JP, Grathwohl D, Labaune JM, Hascoet JM, de Montgolfier I, Leclaire M, Giarre M, Steenhout P. Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Am J Clin Nutr 2008;87:1365-73.
9. Wang KX, Denhardt DT. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008;19:333-45.
10. Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med 2000;11:279-303.
11. Lund SA, Giachelli CM, Scatena M. The role of osteopontin in inflammatory processes. J Cell Commun Signal 2009;3:311-22.
12. Renkl AC, Wussler J, Ahrens T, Thoma K, Kon S, Uede T, Martin SF, Simon JC, Weiss JM. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 2005;106:946-55.
13. Lund SA, Wilson CL, Raines EW, Tang J, Giachelli CM, Scatena M. Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin. J Cell Biochem 2013;114:1194-202.
14. Zhang XF, Liu S, Zhou YJ, Zhu GF, Foda HD. Osteopontin protects against hyperoxia-induced lung injury by inhibiting nitric oxide synthases. Chin Med J (Engl) 2010;123:929-35.
15. Yokosaki Y, Tanaka K, Higashikawa F, Yamashita K, Eboshida A. Distinct structural requirements for binding of the integrins αvβ6, αvβ3, αvβ5, α5β1 and α9β1 to osteopontin. Matrix Biol 2005;24:418-27.
16. Schack L, Lange A, Kelsen J, Agnholt J, Christensen B, Petersen TE, Sørensen ES. Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas. J Dairy Sci 2009;92:5378-85.
17. Schack L, Stapulionis R, Christensen B, Kofod-Olsen E, Skov Sørensen UB, Vorup-Jensen T, Sørensen ES, Höllsberg P. Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J Immunol 2009;182:6943-50.
18. Sørensen ES, Hojrup P, Petersen TE. Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci 1995;4:2040-9.
19. Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sørensen ES. Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem J 2005; 390:285-92.
20. Christensen B, Schack L, Klaning E, Sørensen ES. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D. J Biol Chem 2010; 285:7929-37.
21. Bayless KJ, Davis GE, Meininger GA. Isolation and biological properties of osteopontin from bovine milk. Protein Expr Purif 1997;9:309-14.
22. Kunz C, Lönnerdal B. Protein composition of rhesus monkey milk: Comparison to human milk. Comp Biochem Physiol Comp Physiol. 1993;104:793-7.
23. R: A language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. ISBN 3-900051-07-0 [Internet]; 2013. Available from: http://www.R-project.org/.
24. Wu Z, Irizarry RA. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol 2005;12:882-93.
25. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:1544-6115.
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc, B 1995;57:289-300.
27. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005;4: 1544-6115.
28. Langfelder P, Horvath S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 2008;9:559.
29. Nucleotide Database [Internet]. Rockville (MD): National Center for Biotechnology Information, U.S. National Library of Medicine. 2005 [cited 2013 October 30]. Available from: http://www.ncbi.nlm.nih.gov/ nuccore/.
30. MetaCore Quick Reference Guide [Internet]. Philadelphia: Thomson Reuters [updated 2013 Dec 10] Available from: http://ftp.genego.com/ files/A4_MetaCore_qrg_en.pdf.
31. Lönnerdal B. Infant formula and infant nutrition: Bioactive proteins of human milk and implications for composition of infant formulas. Am J Clin Nutr 2014;99:7125-75.
32. Chatterton DEW, Rasmussen JT, Heegaard CW, Sørensen ES, Petersen TE. In vitro digestion of novel milk protein ingredients for use in infant formulas: Research on biological functions. Trends Food Sci Technol 2004;15:373-83.
33. Gale C, Logan KM, Santhakumaran S, Parkinson JR, Hyde MJ, Modi N. Effect of breastfeeding compared with formula feeding on infant body composition: a systematic review and meta-analysis. Am J Clin Nutr 2012;95:656-69.
34. Rodriguez DE, Thula-Mata T, Toro EJ, Yeh YW, Holt C, Holliday LS, Gower LB. Multifunctional role of osteopontin in directing intrafibrillar mineralization of collagen and activation of osteoclasts. Acta Biomater 2014;10:494-507.
35. Chatakun P, Nunez-Toldra R, Diaz Lopez EJ, Gil-Recio C, Martinez-Sarra E, Hernandez-Alfaro F, Ferrés-Padrós E, Giner-Tarrida L, Atari M. The effect of five proteins on stem cells used for osteoblast differentiation and proliferation: a current review of the literature. Cell Mol Life Sci 2014;71:113-42.
36. Hernell O, Lönnerdal B. Is iron deficiency in infants and young children common in Scandinavia and is there a need for enforced primary prevention? Acta Paediatr 2004;93:1024-6.
37. Andersson Y, Hammarström ML, Lönnerdal B, Graverholt G, Fält H, Hernell O. Formula feeding skews immune cell composition toward adaptive immunity compared to breastfeeding. J Immunol 2009;183: 4322-8.
38. Donovan SM. Role of human milk components in gastrointestinal development: current knowledge and future needs. J Pediatr 2006;149: Suppl 5:S49-61.
39. Chapkin RS, Zhao C, Ivanov I, Davidson LA, Goldsby JS, Lupton JR, Mathai RA, Monaco MH, Rai D, Russell WM, et al. Noninvasive stoolbased detection of infant gastrointestinal development using gene expression profiles from exfoliated epithelial cells. Am J Physiol Gastrointest Liver Physiol 2010;298:G582-9.
40. Kedinger V, Nepveu A. The roles of CUX1 homeodomain proteins in the establishment of a transcriptional program required for cell migration and invasion. Cell Adh Migr 2010;4:348-52.
41. Sansregret L, Nepveu A. The multiple roles of CUX1: Insights from mouse models and cell-based assays. Gene 2008;412:84-94.
42. Kedinger V, Sansregret L, Harada R, Vadnais C, Cadieux C, Fathers K, Park M, Nepveu A. p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin. J Biol Chem 2009;284:27701-11.
43. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80.
44. Brantjes H, Barker N, van Es J, Clevers H. TCF: Lady justice casting the final verdict on the outcome of wnt signalling. Biol Chem 2002;383: 255-61.
45. Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res 2003;284:2-13.
46. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, Chaturvedi R, Peek RM Jr., Wilson KT, Polk DB. Colon-specific delivery of a probioticderived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 2011;121:2242-53.
47. Hu T, Li C. Convergence between Wnt-b-catenin and EGFR signaling in cancer. Mol Cancer 2010;9:236. (DOI: 10.1186/1476-4598-9-236).
48. Teufel A, Wong EA, Mukhopadhyay M, Malik N, Westphal H. FoxP4, a novel forkhead transcription factor. Biochim Biophys Acta 2003; 1627:147-52.
49. LuMM, Li S, Yang H, Morrisey EE. Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues. Mech Dev 2002;119: Suppl 1:S197-202.
50. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (eta-1). Science 1996;271:509-12.
51. Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J Cell Physiol 2004;198:155-67.
52. Mariadason JM, Nicholas C, L'Italien KE, Zhuang M, Smartt HJ, Heerdt BG, Yang W, Corner GA, Wilson AJ, Klampfer L, et al. Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis. Gastroenterology 2005;128:1081-8.
53. Reich NC. A death-promoting role for ISG54/IFIT2. J Interferon Cytokine Res 2013;33:199-205.
54. Morales DJ, Lenschow DJ. The antiviral activities of ISG15. J Mol Biol 2013;425:4995-5008.
55. Santin I, Moore F, Grieco FA, Marchetti P, Brancolini C, Eizirik DL. USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis. Cell Death Dis 2012;3:e419.
56. Kaetzel CS. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev 2005;206:83-99.
57. Heneghan AF, Pierre JF, Kudsk KA. JAK-STAT and intestinal mucosal immunology. JAK-STAT 2013;2:e25530.
58. Koh HS, Matsui A, Mimura S, Inao M, Saitoh E, Ohno A, Nagoshi S, Yoshimoto T, Mochida S, Fujiwara K. Increased cytoprotective function in the liver of transgenic mice expressing osteopontin in hepatocytes. Hepatol Res 2005;32:46-51.
59. Cenik ES, Zamore PD. Argonaute proteins. Curr Biol 2011;21:R446-9.
60. Ércés D, Varga G, Fazekas B, Kovács T, Tkés T, Tiszlavicz L, Fülöp F, Vécsei L, Boros M, Kaszaki J. N-methyl-D-aspartate receptor antagonist therapy suppresses colon motility and inflammatory activation six days after the onset of experimental colitis in rats. Eur J Pharmacol 2012;691:225-34.
61. Chang C, Hemmati-Brivanlou A. Xenopus GDF6, a new antagonist of noggin and a partner of BMPs. Development 1999;126:3347-57.
62. Settle SH Jr., Rountree RB, Sinha A, Thacker A, Higgins K, Kingsley DM. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol 2003; 254:116-30.
63. Standal T, Borset M, Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 2004;26: 179-84.
64. Chatterton DE, Nguyen DN, Bering SB, Sangild PT. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol 2013;45:1730-47.